| Vermillion Announces Notice of Issuance of United States Patent Covering Hepcidin as a Biomarker for Ovarian Cancer.: An article from: BIOTECH Patent News | Digitalby Unavailable (Author)
| List Price: | $9.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Biotech Patent News | | Page Count: | 2 Pages | | Publication Date: | February 01, 2009 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2009. The length of the article is 497 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Vermillion Announces Notice of Issuance of United States Patent Covering Hepcidin as a Biomarker for Ovarian Cancer.Author: UnavailablePublication: BIOTECH Patent News (Newsletter)Date: February 1, 2009Publisher: Biotech Patent NewsVolume: 23 Issue: 2Distributed by Gale, a part of Cengage Learning |
|
